A soft mist inhaler made by Resyca BV, a joint venture of Medspray Pharma BV and Recipharm AB, is being brought to patients with pulmonary arterial hypertension (PAH).
The US Food and Drug Administration (FDA) has decided against
restricting the use of drug-eluting cardiac stents after a two-day
investigation into their potential to increase blood clots.
UK company Biocompatibles has teamed up with a microfluidics
specialist Q Chip to develop a system to improve the manufacture of
microspheres used in drug delivery and medical devices.
Medical device company Boston Scientific has launched a new
cardiovascular stent designed to deliver the drug paclitaxel in 18
countries around the world, stealing a march on arch-rival Johnson
& Johnson.